Fol. Biol. 2017, 63, 202-208
https://doi.org/10.14712/fb2017063050202
Comparison of Subtypes of Hepatocellular Adenoma to Hepatocellular Carcinoma and Non-Neoplastic Liver Tissue in Terms of PTEN Expression
References
1. 2015) Management of hepatocellular adenoma: recent advances. Clin. Gastroenterol. Hepatol. 13, 1221-1230.
< , S., Agarwal, S., Arnason, T., Saini, S., Belghiti, J. (https://doi.org/10.1016/j.cgh.2014.05.023>
2. 2016) A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells. Cell Cycle 15, 573-583.
< , G., Puleio, R., Emma, M. R., Cusimano, A., Loria, G. R., McCubrey, J. A., Montalto, G., Cervello, M. (https://doi.org/10.1080/15384101.2016.1138183>
3. 2015) PTEN expression in colorectal adenomas: relationship to morphology and cell heterogeneity. Pathol. Res. Pract. 211, 248-251.
< , M., Badescu, A., Handra-Luca, A. (https://doi.org/10.1016/j.prp.2014.12.007>
4. 2016) Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis. Mod. Pathol. 29, 43-50.
< , J., Nault, J. C., Balabaud, C., Couchy, G., Saint- Paul, M. C., Azoulay, D., Mehdaoui, D., Luciani, A., Zafrani, E. S., Bioulac-Sage, P., Zucman-Rossi, J. (https://doi.org/10.1038/modpathol.2015.119>
5. 2017) Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens. Hum. Pathol. 63, 1-13.
< , W. T., Ramachandran, R., Kakar, S. (https://doi.org/10.1016/j.humpath.2016.12.025>
6. 2004) PTEN regulatory functions in tumor suppression and cell biology. Med. Sci. Monit. 10, RA235-241.
, E. C., Tarnawski, A. S. (
7. 2014) PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine. J. Pathol. 233, 27-38.
< , E. J., Marsh Durban, V., Meniel, V., Williams, G. T., Clarke, A. R. (https://doi.org/10.1002/path.4312>
8. 2001) Hepatocellular carcinoma: an update. Ultrastruct. Pathol. 25, 497-516.
< , H., Gaytan-Graham, S. (https://doi.org/10.1080/019131201753343539>
9. 2003) Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer 97, 1929-1940.
< , T. H., Huang, C. C., Lin, P. R., Chang, H. W., Ger, L. P., Lin, Y. W., Changchien, C. S., Lee, C. M., Tai, M. H. (https://doi.org/10.1002/cncr.11266>
10. 2004) PTEN function: how normal cells control it and tumour cells lose it. Biochem. J. 382, 1-11.
< , N. R., Downes, C. P. (https://doi.org/10.1042/BJ20040825>
11. 2014) Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis. Mod. Pathol. 27, 420-432.
< , T. C., Vachharajani, N., Chapman, W. C., Brunt, E. M. (https://doi.org/10.1038/modpathol.2013.148>
12. 1963) Cowden’s disease. A possible new symptom complex with multiple system involvement. Ann. Intern. Med. 58, 136-142.
< , K. M., 2nd, Dennis, M. (https://doi.org/10.7326/0003-4819-58-1-136>
13. 2017) Effects of PTEN gene silencing on invasion and EMT in oral squamous carcinoma Tca8113 cells. J. Oral. Pathol. Med. 46, 31-38.
< , Z., Guo, H., Lin, Y., Shen, L., Yin, C., Xie, S. (https://doi.org/10.1111/jop.12461>
14. 1997) Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis. Am. J. Hum. Genet. 61, 1254-1260.
< , E. D., Ostermeyer, E. A., Lee, M. K., Arena, J. F., Ji, H., Dann, J., Swisshelm, K., Suchard, D., MacLeod, P. M., Kvinnsland, S., Gjertsen, B. T., Heimdal, K., Lubs, H., Moller, P., King, M. C. (https://doi.org/10.1086/301639>
15. 2008) Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation. Nat. Genet. 40, 1436-1444.
< , V., Winton, D. J., Williams, G. T., Dubois, N., Trumpp, A., Sansom, O. J., Clarke, A. R. (https://doi.org/10.1038/ng.256>
16. 2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133, 647-658.
< , F., Henson, R., Wehbe-Janek, H., Ghoshal, K., Jacob, S. T., Patel, T. (https://doi.org/10.1053/j.gastro.2007.05.022>
17. 2013) Functions and regulation of the PTEN gene in colorectal cancer. Front. Oncol. 3, 326.
, F., Frattini, M. (
18. 2015) Changes in immunoexpression of p53, Ki-67, Ets-1, APAF-1 and PTEN in serrated and conventional colon adenomas. Rom. J. Morphol. Embryol. 56, 1389-1396.
, Z., Ilyes, I. A., Mocan, S. L., Denes, L., Muica Nagy- Bota, M. C., Pavai, Z., Szanto, A. (
19. 2016) Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma. Clin. Mol. Hepatol. 22, 199-211.
< , M., Sciarra, A., Tommaso, L. D. (https://doi.org/10.3350/cmh.2016.0101>
20. 2014) Histopathology of hepatocellular carcinoma. World J. Gastroenterol. 20, 15955-15964.
< , M., Terracciano, L. M., D’Angelo, S., Sorrentino, P. (https://doi.org/10.3748/wjg.v20.i43.15955>
21. 2011) Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques. Adv. Anat. Pathol. 18, 438-445.
< , N., Kakar, S. (https://doi.org/10.1097/PAP.0b013e318234abb4>
22. 2016) A study on promoter methylation of PTEN in sporadic breast cancer patients from North India. Breast Cancer 23, 922-931.
< , S., Akhter, N., Deo, S. V., Shukla, N. K., Husain, S. A. (https://doi.org/10.1007/s12282-015-0665-0>
23. 2017) Epigenetic downregulation of PTEN in gallbladder cancer. J. Gastrointest. Cancer 48, 110-116.
< , D. S., Gupta, S., Shrivastav, B. R., Tiwari, P. K. (https://doi.org/10.1007/s12029-017-9919-8>
24. 2015) PTEN expression in endothelial cells is down-regulated by uPAR to promote angiogenesis. Thromb. Haemost. 114, 379-389.
< , M., Chilla, A., Pausz, C., Mawas, R., Breuss, J., Zielinski, C., Schabbauer, G., Prager, G. W. (https://doi.org/10.1160/TH15-01-0016>
25. 2017) PTEN plays dual roles as a tumor suppressor in osteosarcoma cells. J. Cell. Biochem. 118, 2684-2692.
< , Y., Chen, Y. (https://doi.org/10.1002/jcb.25888>
26. 2017) Electric field-induced suppression of PTEN drives epithelial- to-mesenchymal transition via mTORC1 activation. J. Dermatol Sci, 85, 96-105.
< , T., Jiang, X., Guo, X., Chen, W., Tang, D., Zhang, J., Zhang, X., Zhang, D., Zhang, Q., Jia, J., Huang, Y. (https://doi.org/10.1016/j.jdermsci.2016.11.007>
27. 2015) Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma. Acta Pharmacol. Sin. 36, 1237-1245.
< , Z. L., Huang, Y., Li, L. F., Zhu, H. L., Gao, H. X., Liu, H., Lv, S. Q., Xu, Z. H., Zheng, L. N., Liu, T., Zhang, J. L., Jin, H. J., Qian, Q. J. (https://doi.org/10.1038/aps.2015.18>
28. 2016) MicroRNA-616 promotes the migration, invasion and epithelial-mesenchymal transition of HCC by targeting PTEN. Oncol. Rep. 35, 366-374.
< , D., Zhou, P., Wang, W., Wang, X., Li, J., Sun, X., Zhang, L. (https://doi.org/10.3892/or.2015.4334>